Michael Gelband’s GenMark Diagnostics, Inc GNMK Stock Holding History

Michael Gelband’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,273	Closed	-$246K	–	3060
2021 Q1	$246K	Buy	+10,273	New	+$191K	﹤0.01%	1778
2019 Q4	–	Sell	-16,156	Closed	-$98K	–	2027
2019 Q3	$98K	Buy	+16,156	New	+$101K	﹤0.01%	1232

Michael Gelband's GNMK Position: Q2 2021 in Review

Michael Gelband sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 10,273 shares — an estimated $246K sold.

Michael Gelband first reported a position in GNMK in Q3 2019 and held it in 2 quarters. The position peaked at $246K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Michael Gelband reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Michael Gelband sold 10,273 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $246K.
Michael Gelband first reported a position in GenMark Diagnostics, Inc in Q3 2019 and held it in 2 quarters.
Michael Gelband's GenMark Diagnostics, Inc position peaked at $246K in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.